Market Place
Sourcing Support
All News #Library
Biotech
Regeneron Scraps 2Seventy`s CAR T For Lymphoma In Strategic Move
24 Oct 2025 //
BIOSPACE
BMS, 2seventy scrap Abecma trial in first-line multiple myeloma
26 Sep 2024 //
FIERCE PHARMA
2sevent sale of Hemophilia A Candidate And Gene Editing Technology to Novo
26 Jun 2024 //
BUSINESSWIRE
2seventy Bio Divests Hemophilia and Gene-Editing to Novo Nordisk
25 Jun 2024 //
FIERCE BIOTECH
BMS` Abecma wins earlier myeloma nod with updated boxed warning
06 Apr 2024 //
FIERCE PHARMA
BMS and 2seventy bio Provide Update on U.S. FDA Review of sBLA for Abecma
20 Nov 2023 //
BUSINESSWIRE
2seventy bio Announces Clinical Study Pause of PLAT-08 Trial of SC-DARIC33
14 Jun 2023 //
BUSINESSWIRE
2seventy bio Presents Late-Breaking Results for SC-DARIC33
19 May 2023 //
BUSINESSWIRE
2seventy Presents Data Highlighting Approaches Across Cell Therapies Portfolio
17 May 2023 //
PRESS RELEASE
2seventy bio to Present Data from Investigational Cell Therapies at the ASGCT
02 May 2023 //
PRESS RELEASE
2seventy bio and Novo Nordisk Collaboration Delivers Key Proof of Concept Data
01 May 2023 //
PRESS RELEASE
Milestone Monday for Immatics’ Bristol Myers-allied cell therapy & 2seventy bio
01 May 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.